新聞/Reuters/UK's MHRA Approves Nogapendekin Alfa Inbakicept To Treat Patients With A Type Of Bladder CancerUK's MHRA Approves Nogapendekin Alfa Inbakicept To Treat Patients With A Type Of Bladder CancerRefinitiv閱讀少於1分鐘UK's MHRA:UK'S MHRA: APPROVES NOGAPENDEKIN ALFA INBAKICEPT TO TREAT ADULT PATIENTS WITH NON-MUSCLE INVASIVE BLADDER CANCER - WEBSITEReuters美國股票英國股票© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.html顯示更多登入或建立一個永久免費帳戶來閱讀此新聞讓我們開始吧
